Apheresis Market Expected to Reach $5.3 Billion by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Apheresis Market," The apheresis market was valued at $2.4 billion in 2021, and is estimated to reach $5.3 billion by 2031, growing at a CAGR of 8.3% from 2022 to 2031. 

Apheresis procedures involve separation of desired components from the blood, while the remaining is either returned to the donor or the patient body. The whole blood is transformed within an instrument that is essentially designed as a centrifuge, the components of whole blood are separated. One of the separated portions is then withdrawn and the remaining components are re-transfused into the patient or donor. There are various methods such as centrifugation, membrane separation, and selective adsorption that are used for apheresis. 

The key Apheresis market trends that drive the market growth include, rise in the demand for blood components across the globe, and government initiative for the blood donation camp. In addition, there is approval for apheresis treatment such as cardiac neonatal lupus, autoimmune hemolytic anemia and acute disseminated encephalomyelitis supplement the Apheresis market growth. Plasma donation treatment has increased in the treatment of burnt patients, trauma patients, and patients suffering from serious disorders or major injuries, which drives the growth of the market. The global apheresis equipment is primarily driven by increase in incidence of chronic diseases worldwide, rise in number of platelet donors, and spike in R&D investments made by biotech and pharmaceutical companies. In October 2020, Hemonetics, blood management product company, received product approval from FDA (Food and Drug Administration) for NexSys PCS with persona technology, which customizes plasma collection based on an individual donor's body composition. 

Plasma is widely used in renal & metabolic diseases and hematologic & neurologic disorders, which helps the market to grow. The disposable products that are used in apheresis drive the market and contribute to the highest growth as there are extensive advancements that are taking place in the development of blood bags, tubing, and disposable kits; however, the same segment is expected to witness considerable growth during the forecast period.  There is increase in the platelets donation and plasma donation, which drives the growth of the market. 

COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The apheresis market is expected to be positively impacted during the COVID-19 pandemic owing to the extensive application of plasma therapy in the treatment of COVID-19 infected patients.

Apheresis market is segmented into product, method, procedure, component, end user, and region. On the basis of product, the market is classified into devices, disposable & reagents, and software. By method, it is categorized into centrifugation, membrane separation, and selective adsorption. Depending on procedure, it is divided into donor/automated apheresis and therapeutic apheresis. According to component, it is fragmented into plasma (plasmapheresis), platelets (plateletpheresis), leukocytes (leukapheresis), lymphocytes (lymph apheresis), and RBCS (erythropheresis). Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Based on product, the disposable & reagent segment has largest market share in 2021, and this trend is expected to continue during the forecast period, due to the extensive advancements that are taking place in the development of blood bags, tubing, and disposable kits. However, the same segment is expected to witness considerable growth during the forecast period. 

By procedure, the donor/automated segment dominated the market in 2021, and this trend is expected to continue during the forecast period, as blood centers have major share in the global apheresis market, which supplement the growth of the donor apheresis segment. Furthermore, surge in apheresis platelet donation and apheresis plasma donations have contributed to the market growth.

However, the therapeutic apheresis segment is expected to witness considerable growth during the forecast period. Owing to rise in patient base suffering from chronic disorders, apheresis is performed for the removal of disease mediator in plasma (autologous/allogenic antibodies), removal diseased cells (sickle or parasite-infected red cells), removal of excess cells (essential thrombocythemia), and replacement with normal blood components. 

By method, the centrifugation segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to the predominant use of centrifugation in the preparation of blood components such as packed red blood cells (PRBCs) and fresh frozen plasma (FFP) in a single-step heavy spin.

However, the membrane separation segment is expected to witness considerable growth during the forecast period, as membrane filters play a pivotal role in filtration of plasma from other cellular components to achieve specific cell separation.

By component, the plasma (plasmapheresis) segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to its wide utilization across renal & metabolic diseases and hematologic & neurologic disorders.

However, the platelet pheresis segment is expected to witness considerable growth during the forecast period, due to soaring number of platelet apheresis procedures across the globe.

By end user, blood centers segment dominated the Apheresis market share in 2021, and this trend is expected to continue during the forecast period, as donor apheresis forms a major constituent of the apheresis industry, and maximum donor apheresis procedures are performed in the blood centers across the globe.

However, the other end user segment is expected to witness considerable growth during the forecast period, as biopharmaceutical manufacturers are the major contributors to the robust growth of this segment, owing to increase in demand for plasma-based drugs.

Region-wise, North America dominated the Apheresis market size in 2021, and is expected to be dominant during the forecast period, owing to the early adoption of novel apheresis systems and increase in prevalence of blood-related disorders in this region. 

However, Asia-Pacific is expected to register highest CAGR of 9.3% from 2022 to 2030, owing to presence of high population base and increase in geriatric population (more susceptible to chronic injuries and disorders). 

KEY FINDINGS OF THE STUDY 
•    By product, the disposable & reagent segment was the highest contributor to the market in 2021.
•    On the basis of procedure, the donor/automated segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
•    On the basis of method, the centrifugation segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
•    On the basis of component, the plasma (plasmapheresis) segment dominated the market in 2021, and is expected to continue this trend during the forecast period. 
•    On the basis of end user, blood centers segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
•    Region-wise, North America garnered the largest revenue share in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.